Author
Listed:
- Marion V. Guerin
(Université de Paris, Institut Cochin, INSERM, U1016, CNRS, UMR8104, F-75014)
- Fabienne Regnier
(Université de Paris, Institut Cochin, INSERM, U1016, CNRS, UMR8104, F-75014)
- Vincent Feuillet
(Université de Paris, Institut Cochin, INSERM, U1016, CNRS, UMR8104, F-75014)
- Lene Vimeux
(Université de Paris, Institut Cochin, INSERM, U1016, CNRS, UMR8104, F-75014)
- Julia M. Weiss
(Université de Paris, Institut Cochin, INSERM, U1016, CNRS, UMR8104, F-75014
University Medical Center)
- Georges Bismuth
(Université de Paris, Institut Cochin, INSERM, U1016, CNRS, UMR8104, F-75014)
- Gregoire Altan-Bonnet
(National Cancer Institute)
- Thomas Guilbert
(Université de Paris, Institut Cochin, INSERM, U1016, CNRS, UMR8104, F-75014)
- Maxime Thoreau
(Université de Paris, Institut Cochin, INSERM, U1016, CNRS, UMR8104, F-75014)
- Veronica Finisguerra
(Ludwig Institute for Cancer Research, de Duve Institute, Université catholique de Louvain)
- Emmanuel Donnadieu
(Université de Paris, Institut Cochin, INSERM, U1016, CNRS, UMR8104, F-75014)
- Alain Trautmann
(Université de Paris, Institut Cochin, INSERM, U1016, CNRS, UMR8104, F-75014)
- Nadège Bercovici
(Université de Paris, Institut Cochin, INSERM, U1016, CNRS, UMR8104, F-75014)
Abstract
Type I interferons (IFN) are being rediscovered as potent anti-tumoral agents. Activation of the STimulator of INterferon Genes (STING) by DMXAA (5,6-dimethylxanthenone-4-acetic acid) can induce strong production of IFNα/β and rejection of transplanted primary tumors. In the present study, we address whether targeting STING with DMXAA also leads to the regression of spontaneous MMTV-PyMT mammary tumors. We show that these tumors are refractory to DMXAA-induced regression. This is due to a blockade in the phosphorylation of IRF3 and the ensuing IFNα/β production. Mechanistically, we identify TGFβ, which is abundant in spontaneous tumors, as a key molecule limiting this IFN-induced tumor regression by DMXAA. Finally, blocking TGFβ restores the production of IFNα by activated MHCII+ tumor-associated macrophages, and enables tumor regression induced by STING activation. On the basis of these findings, we propose that type I IFN-dependent cancer therapies could be greatly improved by combinations including the blockade of TGFβ.
Suggested Citation
Marion V. Guerin & Fabienne Regnier & Vincent Feuillet & Lene Vimeux & Julia M. Weiss & Georges Bismuth & Gregoire Altan-Bonnet & Thomas Guilbert & Maxime Thoreau & Veronica Finisguerra & Emmanuel Don, 2019.
"TGFβ blocks IFNα/β release and tumor rejection in spontaneous mammary tumors,"
Nature Communications, Nature, vol. 10(1), pages 1-12, December.
Handle:
RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-11998-w
DOI: 10.1038/s41467-019-11998-w
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-11998-w. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.